Qingming Xia Selected Research

Immunotherapy

1/2022	Tumor Microenvironment Multiple Responsive Nanoparticles for Targeted Delivery of Doxorubicin and CpG Against Triple-Negative Breast Cancer.
9/2018	Functionalized Multi-Walled Carbon Nanotubes for Targeting Delivery of Immunostimulatory CpG Oligonucleotides Against Prostate Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qingming Xia Research Topics

Disease

4	Neoplasms (Cancer) 01/2022 - 11/2017
3	Breast Neoplasms (Breast Cancer) 01/2022 - 09/2016
3	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2018
1	Triple Negative Breast Neoplasms 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 10/2018
1	Colonic Neoplasms (Colon Cancer) 10/2018
1	Lung Neoplasms (Lung Cancer) 11/2016
1	Necrosis 09/2016

Drug/Important Bio-Agent (IBA)

5	Peptides (Polypeptides)IBA 01/2022 - 09/2016
4	MicellesIBA 01/2022 - 09/2016
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 09/2016
2	OligodeoxyribonucleotidesIBA 01/2022 - 09/2018
2	Nanoparticle Drug Delivery SystemIBA 01/2022 - 09/2018
2	LigandsIBA 10/2018 - 09/2016
2	Carbon Nanotubes (Carbon Nanotube)IBA 09/2018 - 01/2018
2	Docetaxel (Taxotere)FDA Link 11/2017 - 11/2016
2	Thioctic Acid (Lipoic Acid)IBA 11/2016 - 09/2016
1	AntibodiesIBA 10/2018
1	OligonucleotidesIBA 09/2018
1	Contrast MediaIBA 01/2018
1	cyanine dye 5IBA 11/2017
1	Indicators and Reagents (Reagents)IBA 11/2017
1	Small Interfering RNA (siRNA)IBA 11/2017
1	Arginine (L-Arginine)FDA Link 09/2016
1	Histidine (L-Histidine)FDA Link 09/2016
1	DisulfidesIBA 09/2016

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 01/2022 - 11/2017
2	Therapeutics 01/2022 - 11/2017
2	Immunotherapy 01/2022 - 09/2018